Other nonneoplastic disorders
Gaucher disease

Author: Jaleh Mansouri, M.D. (see Authors page)

Revised: 2 March 2018, last major update October 2012

Copyright: (c) 2003-2018, PathologyOutlines.com, Inc.

PubMed Search: Gaucher disease[TI] spleen[TIAB] free full text[sb]

Cite this page: Mansouri, J. Gaucher disease. PathologyOutlines.com website. http://www.pathologyoutlines.com/topic/spleengaucher.html. Accessed July 16th, 2018.
Definition / general
  • Autosomal recessive disease, due to accumulation of glucocerebroside (a sphingolipid) in reticuloendothelial cells in liver, spleen and bone marrow, due to a defect in lysosomal beta glucocerebrosidase
  • Increased risk (14x) of hematologic malignancies and 4x for other malignancies
  • Type 1: chronic nonneuronopathic form - often completely asymptomatic; disease discovered incidentally; does not involve the nervous system, high prevalence among Ashkenazi Jews (1/12 are carriers)
  • Type 2: fatal neurodegenerative disorder of infancy, similar to Tay-Sachs disease
  • Type 3: slowly progressive neurologic disease with survival into adulthood
Case reports
  • Glucocerebrosidase (enzyme replacement therapy)
Gross description
  • Massively enlarged spleens up to 10 kg
Microscopic (histologic) description
  • Marked expansion of red pulp
  • Large number of histiocytes with finely fibrillar cytoplasm (crinkled or wrinkled paper-like), particularly in splenic cords
  • White pulp remains intact
Microscopic (histologic) images

Images hosted on other servers:

Various images

Positive stains
Negative stains
Differential diagnosis